Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruggenenti

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Kidney International. Supplement|June 1, 1996
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetesL Mosconi, P Ruggenenti, A Perna, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 10, 2000
Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injuryP Ruggenenti, A Perna, G Gherardi, et al.
Kidney International|May 9, 1998
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN)P Ruggenenti, A Perna, L Mosconi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1993
Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the diseaseP Ruggenenti, M Galbusera, R P Cornejo, et al.
The International Journal of Artificial Organs|February 26, 2009
Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapyP Cravedi, P Ruggenenti, G Mingardi, et al.
Kidney International|January 3, 2001
Ramipril prolongs life and is cost effective in chronic proteinuric nephropathiesP Ruggenenti, E Pagano, L Tammuzzo, et al.
The American Journal of Physiology|October 1, 1990
Glomerular response to hyperglycemia in human diabetic nephropathyA Remuzzi, G Viberti, P Ruggenenti, et al.
Kidney International|June 1, 1991
Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyA Remuzzi, E Perticucci, P Ruggenenti, et al.
Kidney International|August 1, 1993
Failure to predict cyclosporine area under the curve using a limited sampling strategyF Gaspari, P Ruggenenti, L Torre, et al.
Clinical Transplants|August 22, 2001
The kidney transplant program at the Bergamo CenterG Remuzzi, N Perico, E Gotti, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Kidney International. Supplement|June 1, 1996
Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetesL Mosconi, P Ruggenenti, A Perna, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 10, 2000
Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injuryP Ruggenenti, A Perna, G Gherardi, et al.
Kidney International|May 9, 1998
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN)P Ruggenenti, A Perna, L Mosconi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1993
Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the diseaseP Ruggenenti, M Galbusera, R P Cornejo, et al.
The International Journal of Artificial Organs|February 26, 2009
Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapyP Cravedi, P Ruggenenti, G Mingardi, et al.
Kidney International|January 3, 2001
Ramipril prolongs life and is cost effective in chronic proteinuric nephropathiesP Ruggenenti, E Pagano, L Tammuzzo, et al.
The American Journal of Physiology|October 1, 1990
Glomerular response to hyperglycemia in human diabetic nephropathyA Remuzzi, G Viberti, P Ruggenenti, et al.
Kidney International|June 1, 1991
Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyA Remuzzi, E Perticucci, P Ruggenenti, et al.
Kidney International|August 1, 1993
Failure to predict cyclosporine area under the curve using a limited sampling strategyF Gaspari, P Ruggenenti, L Torre, et al.
Clinical Transplants|August 22, 2001
The kidney transplant program at the Bergamo CenterG Remuzzi, N Perico, E Gotti, et al.
Pageof 10